Lattice Biologics (TSXV:LBL.H) Institutional Ownership : 0.21% (As of Jun. 11, 2024)

View and export this data going back to 1995. Start your Free Trial

What is Lattice Biologics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lattice Biologics's institutional ownership is 0.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lattice Biologics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lattice Biologics's Float Percentage Of Total Shares Outstanding is 0.00%.

Lattice Biologics Institutional Ownership Historical Data

The historical data trend for Lattice Biologics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lattice Biologics Institutional Ownership Chart

Lattice Biologics Historical Data

The historical data trend for Lattice Biologics can be seen below:

	2013-12-31	2014-01-31	2014-02-28	2014-03-31	2014-04-30	2014-05-31	2014-06-30	2014-07-31	2014-08-31	2014-09-30
Institutional Ownership	6.35	4.48	3.99	3.99	3.99	1.83	1.83	1.83	0.21	0.21

Lattice Biologics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Lattice Biologics (TSXV:LBL.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lattice Biologics Ltd (TSXV:LBL.H) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 East Madison Avenue, Suite A1, Belgrade, MT, USA, 59714

Website

http://www.latticebiologics.com

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.

Lattice Biologics (TSXV:LBL.H) Headlines

No Headlines